Skip to content

Clinical trials

Recruiting Carcinoma, Non-Small-Cell Lung trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Recruiting Country / region: Japan Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20181
20203
20215
20224
20238
202416
202531
202617

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting86

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC9
AstraZeneca8
Bristol-Myers Squibb7
Eli Lilly and Company6
AbbVie5
Pfizer5
Novartis Pharmaceuticals4
Astellas Pharma Global Development, Inc.3
Hoffmann-La Roche3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung86
Lung Neoplasms20
Triple Negative Breast Neoplasms13
Neoplasm Metastasis9
Neoplasms9
Squamous Cell Carcinoma of Head and Neck9
Colorectal Neoplasms8
Endometrial Neoplasms8
Ovarian Neoplasms8
Stomach Neoplasms8

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.